Silibinin: Clinical Trials

6 trials of Silibinin, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 2 terminated, 1 active not recruiting, 1 recruiting. 3 Phase 2, 2 Not applicable, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 23Terminated 2, Completed 1
Not applicable2Active not recruiting 1, Recruiting 1
Phase 11Completed 1

Follow Silibinin: new trials by email Literature Review of Silibinin trials Research Report on Silibinin

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
SILibinin in NSCLC and BC Patients With Single Brain METastasis (SILMET)
Silibinin, Placebo - Brain Metastases, Adult, Non Small Cell Lung Cancer
Not applicableRecruitingA.O.U. Città della Salute e della Scienza702023-09-012023-12-15
Prospective Double Arm Randomized Trial: WBRT Alone and WBRT Plus Silibinin
Silibinin - Brain Metastases, Adult
Not applicableActive not recruitingIstituto Clinico Humanitas442023-03-062025-04-24
Trial of Indole-3-Carbinol and Silibinin
Indole-3-Carbinol, Silibinin, Silibin - Smoking
Phase 1CompletedMasonic Cancer Center, University of Minnesota212018-11-292021-08-11
Legalon SIL for the Treatment of HCV Recurrence in Liver Transplanted Patients
Silibinin, Placebo - HCV Recurrence After Liver Transplantation
Phase 2TerminatedRottapharm142010-09-012012-02-17
Intravenous Milk Thistle (Silibinin-Legalon) for Hepatic Failure Induced by Amatoxin/Amanita Mushroom Poisoning
Silibinin - Amatoxin Poisoning, Amanita Poisoning
Phase 2TerminatedMylan Specialty, LP1482009-11-102022-04-07
Intravenous Silibinin in Combination With Peg-interferon and Ribavirin in Nonresponders
Silibinin - Hepatitis C
Phase 2CompletedMedical University of Vienna702007-10-012017-03-27

Conditions studied

Brain Neoplasms (2)  ·  Breast Neoplasms (1)  ·  Carcinoma, Non-Small-Cell Lung (1)  ·  Hepatitis C (1)  ·  Hepatitis C, Chronic (1)  ·  Liver Failure (1)  ·  Mushroom Poisoning (1)  ·  Smoking (1)

Sponsors

A.O.U. Città della Salute e della Scienza (1)  ·  Istituto Clinico Humanitas (1)  ·  Masonic Cancer Center, University of Minnesota (1)  ·  Medical University of Vienna (1)  ·  Mylan Specialty, LP (1)  ·  Rottapharm (1)

Countries

Italy (2)  ·  United States (2)  ·  Austria (1)

Top investigators

Naomi Fujioka, MD (1)  ·  Wallis Marsh, MD (1)  ·  Xavier Forns, Dr (1)

Results publications

PMID 18771667, PMID 20709593, PMID 22155914